-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Evommune to Neutral

Benzinga·06/30/2026 10:41:45
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Evommune (NYSE:EVMN) from Buy to Neutral.